Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 10/20 | 0.58 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.53 |
| ▸ | CTSL | P07711 | 2/20 | 0.51 |
| ▸ | CTSS | P25774 | 2/20 | 0.51 |
| ▸ | CTSK | P43235 | 2/20 | 0.51 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.51 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
| ▸ | CTSH | P09668 | 1/20 | 0.50 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29645132 | 0.90 | CXCR4 (0.62) | CXCR4KISS1RKEAP1PTH1R | |
| SCHEMBL30495593 | 0.89 | CXCR4 (0.69) | CXCR4KISS1RCXCL8 | |
| SCHEMBL19361983 | 0.89 | CXCR4 (0.58) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL31665985 | 0.88 | CXCR4 (0.64) | CXCR4KISS1RCXCL8 | |
| SCHEMBL31556101 | 0.86 | CXCR4 (0.64) | CXCR4KISS1RCTSLCTSSCTSK | |
| SCHEMBL30431356 | 0.86 | CXCR4 (0.66) | CXCR4KISS1RCTSLCTSSCTSK | |
| SCHEMBL29674837 | 0.85 | CXCR4 (0.61) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL29674968 | 0.85 | CXCR4 (0.61) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL29895404 | 0.85 | CXCR4 (0.61) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30381291 | 0.85 | KISS1R (0.56) | CXCR4KISS1RCTSLCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220175955-A1 | PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE | DANMARKS TEKNISKE UNIVERSITET (DK) | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220175955-A1 | PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE | CD74, MICA, TAP1 | CXCR4 844/4885KISS1R 3956/4885CTSL 427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.